chr1-61801625-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001350145.3(PATJ):āc.1405A>Gā(p.Thr469Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,509,136 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001350145.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PATJ | NM_001350145.3 | c.1405A>G | p.Thr469Ala | missense_variant, splice_region_variant | 12/44 | ENST00000642238.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PATJ | ENST00000642238.2 | c.1405A>G | p.Thr469Ala | missense_variant, splice_region_variant | 12/44 | NM_001350145.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000924 AC: 19AN: 205538Hom.: 0 AF XY: 0.0000711 AC XY: 8AN XY: 112514
GnomAD4 exome AF: 0.0000560 AC: 76AN: 1356944Hom.: 1 Cov.: 27 AF XY: 0.0000640 AC XY: 43AN XY: 671530
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.1405A>G (p.T469A) alteration is located in exon 12 (coding exon 11) of the PATJ gene. This alteration results from a A to G substitution at nucleotide position 1405, causing the threonine (T) at amino acid position 469 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at